| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:2507-2510.)
© 2004 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Mayo Foundation, Rochester, Minn.
Correspondence to Virend K. Somers, MD, Dphil, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail somers.virend{at}mayo.edu
Received September 2, 2003; de novo received December 2, 2003; revision received February 5, 2004; accepted February 13, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results We studied 30 subjects (19 men, 11 women; mean age, 41.6 years). All participants underwent polysomnography to exclude obstructive sleep apnea or other sleep disorders. Brachial artery flowmediated endothelium-dependent vasodilation (FMD) and endotheliumindependent dilation (non-FMD) were measured on 3 different occasions: before subjects went to sleep (9 PM), the next morning immediately after waking (6 AM), and during the late morning 5 hours after waking (11 AM). All subjects had normal sleep with good sleep efficiency of 84±2%. Compared with before sleep, FMD decreased markedly in the early morning after waking and recovered by late morning (9 PM, 7.5±1%; 6 AM, 4.4±0.7%; 11 AM, 7.7±1%; P=0.02). Non-FMD was similar for the 3 periods of observation (9 PM, 17.3±1.6%; 6 AM, 17.2±1.3%; 11 AM, 18.5±1.7%).
Conclusions FMD is blunted in the early morning in healthy subjects. Decreased endothelial function in the early morning may have implications for our understanding of the morning peak in cardiac and vascular events.
Key Words: brachial artery endothelium circadian rhythm sleep
| Introduction |
|---|
|
|
|---|
Impaired endothelial function is associated with increased risk for cardiovascular events.1317 Furthermore, acute early morning changes in endothelial function may contribute to the circadian pattern of cardiac and vascular vulnerability.
Whether there is indeed a morning decrease in endothelial function in healthy subjects is controversial. Shaw et al18 reported increased flow-mediated vasodilation in resistance vessels in normal subjects in the morning. Kawano et al19 detected no differences in conduit vessels of healthy subjects in the morning compared with late afternoon, and Elherik et al20 observed a morning decrease in flow-mediated vasodilation as measured by laser Doppler in forearm skin.
High-resolution ultrasound of brachial artery flowmediated dilation, well established as a noninvasive technique to evaluate endothelial function,2123 is significantly associated with Framingham risk factor score23 and provides an index of future cardiovascular risk.1517 We tested the hypothesis that endothelial function is altered in the early morning around the time of waking compared with measurements obtained either before sleep or later in the day.
| Methods |
|---|
|
|
|---|
Vascular Studies
All subjects were asked to abstain from the use of alcohol and caffeine for 24 hours before the study. Studies were performed in patients in the supine position in a quiet, temperature-controlled (24°C to 27°C) room at the General Clinical Research Center. Subjects underwent complete overnight polysomnography to ensure adequate sleep quality and to exclude obstructive sleep apnea or other sleep pathology. Subjects were awakened at 6 AM.
Endothelial function was evaluated by ultrasound measures of flow-mediated endothelium-dependent vasodilation (FMD) and endothelium-independent vasodilation (NFMD) of the brachial artery.21,22,24 FMD and NFMD were measured on 3 occasions: in the evening (9 PM) after
4 hours of fasting, in the early morning (6 AM) after waking and before breakfast, and in the late morning 4 hours after breakfast (11 AM). Blood samples for norepinephrine concentration were also taken on the 3 occasions and analyzed by high-performance liquid chromatography.
The right brachial artery images were acquired above the antecubital fossa in the longitudinal plane of the artery with an Acuson ultrasound machine (Acuson Computed Sonography) with a 6-MHz linear transducer. When the first baseline images were obtained, the skin was marked so that the artery could be scanned at the same place for all 3 observations. A continuous ECG was recorded for timing diastole. Subjects rested undisturbed in the supine position for 10 minutes before each observation period.
Reactive hyperemia (FMD) was induced by inflation of a blood pressure cuff around the forearm to 200 mm Hg for 5 minutes and then released. The diameter of the brachial artery was assessed 60 to 90 seconds after deflation of the cuff. Thereafter, a 10-minute period was allowed for recovery of the vessel, after which a second baseline image of the brachial artery was obtained. A sublingual dose of nitroglycerin tablet (0.4 mg) was administered, and the brachial artery dilation response (NFMD) was assessed by imaging the artery continuously for 4 minutes. The images for measurement of diameter were obtained between the third and fourth minutes of recording. All measurements, acquired by 3 experienced investigators, were stored digitally and recorded on VHS tape.
Diameter Measurements
Brachial artery diameter was measured at the onset of the R wave, and an average of 5 measurements from 3 cardiac cycles was used. Measurements were made manually offline on a workstation by 2 blinded investigators. The intraobserver reproducibility was 95%, and the interobserver reproducibility was 93%.
Statistical Analysis
The percent changes in FMD and NFMD were compared for the 3 different time points. Values are expressed as mean±SE. Baseline measurements obtained during the 3 different observations were compared by use of ANOVA. The percent variations of diameter among the 3 observations were compared by use of MANOVA. For nonparametric analysis, Wilcoxons rank test was used. Data were analyzed with JMP software (Statistical Discovery Software from SAS). A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
FMD Findings
FMD at 6 AM was markedly decreased compared with the measurements at 9 PM and 11 AM (9 PM, 7.5±1%; 6 AM, 4.4±0.7%; 11 AM, 7.7±1%; P=0.02) (the Figure).
|
The trend toward decreased endothelial function was present in the morning in both men and women. In women, brachial artery dilation was 7.4±0.9% at 9 PM, decreasing to 5.0±1.3% at 6 AM (P=0.07) and recovering to 8.1±1.6% at 11 AM (P=0.11). The findings were similar in men, with brachial artery dilation decreasing from 7.5±1.4% at 9 PM to 4.0±0.8% at 6 AM (P=0.03) and improving to 7.4±1.2 at 11 AM (P=0.01). There were no differences in changes from 9 PM to 6 AM and to 11 AM between men and women.
NFMD Findings
Percent changes in brachial artery diameter after nitroglycerin (NFMD) were similar at the 3 observations (9 PM, 17.3±1.6%; 6 AM, 17.2±1.3%; 11 AM, 18.5±1.7%; P=0.61) (the Figure). Findings were very similar in both women (9 PM, 21.4±2.4%; 6 AM, 19.0±2.5%; 11 AM, 21.2±2.5%; P=0.6) and men (9 PM, 15.5±1.8%; 6 AM, 15.6±1.6%; 11 AM, 16.8±2.2%; P=0.7).
| Discussion |
|---|
|
|
|---|
The peak incidence in cardiac events is noted to occur between 6 AM and 11 AM in many studies.1,2,2731 Integrity of endothelial function is important to multiple homeostatic mechanisms that influence cardiovascular risk. These include control of vascular tone, platelet aggregation,32 and fibrinolysis.33 Blunted endothelial function in the early morning hours may predispose to enhanced vasoconstriction and intravascular thrombosis, especially in the setting of increased sympathetic activation11 and heightened
-receptor sensitivity in the early morning.9
Any interrelationship between endothelial function and cardiac event peak would be affected by a number of other considerations, including the time of awakening. Another important consideration is that the pathological processes linking decreased endothelial function to a cardiovascular event are not instantaneous but probably are gradual and complex, perhaps extending over several hours and eventually leading to overt ischemia. Thus, the presence of decreased endothelial function at 6 AM may be linked with the beginning of the cardiovascular event surge. Furthermore, the progressive nature of the development of a coronary thrombosis,34,35 which may persist for hours before progressing to infarction, speaks to the likelihood that reduced endothelial function could contribute to the initiation of a process that may present several hours later in the morning.
Our data contrast with earlier work showing either no change19 or improved endothelial function in the morning18 in small groups of male subjects (10 to 20 volunteers). However, our study is consistent with data showing attenuated skin vasodilation in the early morning hours.20 Nevertheless, changes in skin vascular physiology cannot be easily extrapolated to an understanding of the systemic circulation. Indeed, in many conditions, the responses of the skin vasculature are directly opposite those noted in the muscle and other vascular beds.36,37 Thus, the physiology and pathology of skin blood vessels differ strikingly from other vascular beds, and the implications of changes in the regulation of skin blood vessels for understanding cardiovascular pathophysiology may be limited. Furthermore, although there is compelling evidence linking brachial artery endothelial dysfunction to disease states16,23,26,38 and to poorer cardiovascular prognosis,16,23 little is known about the interaction between skin vasodilation and either cardiovascular disease or prognosis.
One strength of the present study is the polysomnographic confirmation of nighttime sleep quality and the absence of sleep apnea or other sleep disorders. No prior studies have included polysomnographic evaluation. Occult sleep apnea may influence measures of vascular and endothelial function, particularly in the early morning after a night of sleep apnea,24,39 independently of any true physiological fluctuation in vasoregulation. Another strength of this study is that all subjects were healthy and on no medications. Thus, we excluded the possibility that overnight abstinence from vasoactive pharmacotherapy could have elicited an artifactual impairment of morning measures of endothelial function. Additionally, our subjects remained in the laboratory throughout the course of all 3 measurements, limiting the effects of external variables on these measures, allowing endothelial function to be measured consistently around the time of waking from sleep, and allowing confirmation of good sleep quality. Inadequate sleep may also have consequences for circulatory control that, in the absence of measurements of sleep quality, could be misinterpreted as changes secondary to morning fluctuations in cardiovascular physiology.40,41 Finally, the use of nitroglycerin-induced dilation as an internal control makes more robust our findings of a selective impairment of FMD but not NFMD.
A limitation of our study is that we cannot identify the specific mechanisms responsible for the morning-related endothelial impairment. Potential candidates may include increases in sympathetic activation12 and heightened adrenergic receptor sensitivity.9 Insofar as plasma norepinephrine levels are able to detect changes in sympathetic activity, and in agreement with data from Schofl et al,42 we did not observe any increase in norepinephrine, blood pressure, or heart rate in the morning. A further limitation relates to data from Hjalmarson et al,43 who observed a lower second peak in the incidence of myocardial infarction in patients with congestive heart failure, those with nonQ-wave infarction, smokers, and diabetics. Our study was not designed to address this secondary peak, and we cannot draw inferences regarding the potential mechanism involved.
In conclusion, we have noted a significant reduction in morning levels of endothelium-mediated vasodilation in healthy subjects. This morning decrease in flow-mediated vasodilation needs to be recognized in clinical studies of endothelial function so that comparisons of measurements are performed at approximately the same time of day. The morning-related attenuation of endothelial function may also have implications for our understanding of the morning peak in cardiac and vascular events.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Gozal, L. Kheirandish-Gozal, L. D. Serpero, O. Sans Capdevila, and E. Dayyat Obstructive Sleep Apnea and Endothelial Function in School-Aged Nonobese Children: Effect of Adenotonsillectomy Circulation, November 13, 2007; 116(20): 2307 - 2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takeda, K. Maemura, S. Horie, K. Oishi, Y. Imai, T. Harada, T. Saito, T. Shiga, E. Amiya, I. Manabe, et al. Thrombomodulin Is a Clock-controlled Gene in Vascular Endothelial Cells J. Biol. Chem., November 9, 2007; 282(45): 32561 - 32567. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Reilly, E. J. Westgate, and G. A. FitzGerald Peripheral Circadian Clocks in the Vasculature Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1694 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Ainslie, C. Murrell, K. Peebles, M. Swart, M. A. Skinner, M. J. A. Williams, and R. D. Taylor Vascular: Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function Exp Physiol, July 1, 2007; 92(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF] |
||||
![]() |
H. Viswambharan, J. M. Carvas, V. Antic, A. Marecic, C. Jud, C. E. Zaugg, X.-F. Ming, J.-P. Montani, U. Albrecht, and Z. Yang Mutation of the Circadian Clock Gene Per2 Alters Vascular Endothelial Function Circulation, April 24, 2007; 115(16): 2188 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kario Vascular Damage in Exaggerated Morning Surge in Blood Pressure Hypertension, April 1, 2007; 49(4): 771 - 772. [Full Text] [PDF] |
||||
![]() |
B. Cortes, I. Nunez, M. Cofan, R. Gilabert, A. Perez-Heras, E. Casals, R. Deulofeu, and E. Ros Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial Function J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Harris, J. Padilla, L. D Rink, and J. P Wallace Variability of flow-mediated dilation measurements with repetitive reactive hyperemia Vascular Medicine, February 1, 2006; 11(1): 1 - 6. [Abstract] [PDF] |
||||
![]() |
M. E. Young The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H1 - H16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wauschkuhn, K. Witte, S. Gorbey, B. Lemmer, and L. Schilling Circadian periodicity of cerebral blood flow revealed by laser-Doppler flowmetry in awake rats: relation to blood pressure and activity Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1662 - H1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Tschakovsky and K. E. Pyke Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function J Appl Physiol, September 1, 2005; 99(3): 1235 - 1237. [Full Text] [PDF] |
||||
![]() |
J. Hetzel, B. Balletshofer, K. Rittig, D. Walcher, W. Kratzer, V. Hombach, H.-U. Haring, W. Koenig, and N. Marx Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1804 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Klerman Clinical Aspects of Human Circadian Rhythms J Biol Rhythms, August 1, 2005; 20(4): 375 - 386. [Abstract] [PDF] |
||||
![]() |
A. L. Moens, I. Goovaerts, M. J. Claeys, and C. J. Vrints Flow-Mediated Vasodilation: A Diagnostic Instrument, or an Experimental Tool? Chest, June 1, 2005; 127(6): 2254 - 2263. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |